- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02963870
The Cognitive-behavioral Approach, Standard Plan Security on Relapse Suicidal Adolescents (SECURIPLAN)
Randomized Controlled Trial of the Effectiveness of the Cognitive-behavioral Approach, Standard Plan Security on Relapse Suicidal Adolescents
Study Overview
Status
Intervention / Treatment
Detailed Description
The recommendation for the treatment of suicidal adolescents, Cognitive Behavioral Therapy (CBT) targeted new generation offer effective approaches to suicidal crisis and relapse prevention.
Since 2009, our team is engaged in a partnership between France and Quebec Interuniversity agreement concluded by a University Picardie Jules Verne-University of Montreal. In this context, two teams G4 (Amiens and Rouen) have received training in suicidal crisis, including the security plan by a university instructor and TCC Québec, Dr. Labelle. Furthermore, we complete a descriptive and prospective study of risk and protective factors for adolescent suicide in which the Quebec team of Professor Labelle contributes as an expert (sponsor: Rouen). 200 subjects were recruited on 2 years by 3 (CHU Amiens, CH Compiègne, CHU Rouen) with an assessment of recurrence at 1 year (lost rates of view = 15%). The first results highlight the central role of personal coping strategies (coping) in suicidal recurrence. We want extend this study to validate the implementation of the security plan (safety level) with suicidal adolescents. The security plan is the initial step of the TCC approach short of suicidal crisis. It is established after working with adolescents and their families (chain analysis of the suicidal crisis, coping self-evaluation and identification of support resources). Developed by Stanley B from Columbia University and adapted for francophone adolescents R Labelle and JJ Breton wrote this list those resources and coping strategies to apply in case ideation and suicidal crisis. Signed by the young person and his family, he then uses to frame the monitoring and management plan of the youth and his family environment, friendly and professional in case of suicidal crisis.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Jean-Marc GUILE, professor
- Phone Number: +33 322 087 628
- Email: guile.jean-marc@chu-amiens.fr
Study Contact Backup
- Name: AIT AMER MEZIANE Mohamed, PHD
- Phone Number: +33 322 088 384
- Email: aitamermeziane.mohamed@chu-amiens.fr
Study Locations
-
-
-
Amiens, France, 80000
- Recruiting
- CHU Amiens Picardie
-
Contact:
- Jean-marc GUILE, PhD
-
Sub-Investigator:
- Sébatien GARNY DE LA RIVIERE, Dr
-
Caen, France, 14000
- Recruiting
- CHU caen
-
Contact:
- Jean-marc BALEYTE, PhD
-
Sub-Investigator:
- Solène SPIERS, Dr
-
Rouen, France, 76000
- Recruiting
- CHU Charles Nicolle
-
Contact:
- Priscille GERARDIN, PhD
-
Sub-Investigator:
- Malaika Lasfar, Dr
-
Sub-Investigator:
- Agathe Raynal, Dr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adolescents between 12 and 17, boys and girls, hospitalized for attempted suicide
- Adolescents whose parents gave informed consent and who themselves expressed their willingness to participate in research.
- Patients covered by the social insurance system
Exclusion Criteria:
- Clinical situations with self-injury without suicidal intent or suicide attempt
- mental disorders significantly impair the self-assessment questionnaire capacities: Intellectual disability, autism spectrum disorder, acute psychotic state and, psychopathy (including assessment questionnaire Frick) and the active use of alcohol and toxic (DEP teen> 20)
- have benefited a security plan before the study
- adolescents deprived of liberty.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: security plan
groups of adolescents aged 12-17 hospitalized for TS and randomized to a group treated with security plan and the usual treatment
|
This study compared two groups of adolescents aged 12-17 hospitalized for TS and randomized to a group treated with the Security Plan plus the usual treatment and a group receiving standard treatment only.
|
Active Comparator: standard treatment only.
group receiving standard treatment only.
|
This study compared two groups of adolescents aged 12-17 hospitalized for TS and randomized to a group treated with the Security Plan plus the usual treatment and a group receiving standard treatment only.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Occurrence of suicide attempt
Time Frame: 12 months
|
Occurrence of suicide attempt recurrence (documented by CNRS) during the year following randomization.
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Occurrence of relapse Suicide attempt
Time Frame: 6 months
|
Occurrence of relapse Suicide attempt within 6 months of randomization.
|
6 months
|
Observance
Time Frame: 6 months and 12 months
|
Observance at 6 months and 1 year using the categories used in the Giraud study
|
6 months and 12 months
|
coping strategies of the adolescent
Time Frame: 12 months
|
Compare at 1 year the evolution of coping strategies of the adolescent assessed by changes in coping scores assessed by self-questionnaire Friedenberg (ACS) from randomization to 1 year later.
|
12 months
|
Evolution of social support perceived by the teen evaluat
Time Frame: 12 months
|
Compare at 1 year evolution of social support perceived by the teen evaluated by varying the scores of self-questionnaire Sarason (SSQ6) from randomization to 1 year later.
|
12 months
|
Collaborators and Investigators
Investigators
- Study Director: Jean-Marc GUILE, professor, CHU Amiens-Picardie
- Principal Investigator: LEGRAND, Doctor, CHP Philippe Pinel Amiens
- Principal Investigator: GERARDIN, Doctor, CHU de Rouen
- Principal Investigator: BALEYTE, Doctor, University Hospital, Caen
- Principal Investigator: Bernadette BAKHACHE, Doctor, CH St-Quentin
- Principal Investigator: Maud PERCQ, Doctor, EPSMD Aisne
- Principal Investigator: VERVEL, Doctor, CH Compiègne
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PI2015_843_0009
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Treatment of Suicidal Recidivism in Adolescents Population
-
University of IcelandEnrolling by invitationHealthy Adolescents in School-based PopulationIceland
-
Assistance Publique - Hôpitaux de ParisCompletedUse of Methylphenidate in Children and AdolescentsFrance
-
Assistance Publique - Hôpitaux de ParisCompletedOutpatient Use of Analgesics in Children and AdolescentsFrance
-
Centre Hospitalier de TroyesInstitut National de la Santé Et de la Recherche Médicale, FranceNot yet recruitingOSTEOPATHY IN THE TREATMENT OF IBS SYMPTOMS IN ADULTS
-
Solta MedicalCompletedTreatment of Adipose Tissue in the ThighsUnited States, Canada
-
Chantal Biya International Reference Centre for...CompletedCharacterization of HIV Reservoirs in AdolescentsCameroon
-
Shandong UniversityCompletedthe Incidence of Gastrointestinal Diseases Diagnosed by Endoscopy in Physicians and General PopulationChina
-
Fayoum UniversityUnknownCompare Serum Level of Klotho in Patients on Oral Antidiabetic TreatmentEgypt
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingCross Sex Hormonal Treatment in Adolescents With Gender Dysphoria
-
Yonsei UniversityWithdrawnPatients in the Treatment of Subjects With All-comer Who Are to Undergo PCI
Clinical Trials on Security Plan
-
Instituto de Investigación Hospital Universitario...Hospital Universitario La Paz; Fundacion para la Investigacion Biomedica del...CompletedSuicidal Ideation | Suicide, Attempted | SuicideSpain
-
University of SouthamptonUnknownUnipolar DepressionUnited Kingdom
-
Deutsches Herzzentrum MuenchenBayerisches Staatsministerium für Wirtschaft; R & S GmbH und Co KGCompletedElectromagnetic InterferenceGermany
-
Unity Health TorontoActive, not recruitingSocial Determinants of Health | Poverty | IncomeCanada
-
University of Maryland, College ParkEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingParent-Child Relations | Parenting | Development, Infant | Development, ChildUnited States
-
University of Colorado, DenverRecruiting
-
Vastra Gotaland RegionRecruitingParenting | Primary Health Care | Psychological Phenomena and ProcessesSweden
-
UMC UtrechtVrije Universiteit BrusselTerminated
-
Colorado State UniversityUniversity of Colorado, Denver; National Institute of Diabetes and Digestive... and other collaboratorsRecruitingType 2 DiabetesUnited States
-
University of California, San FranciscoWashington University School of Medicine; University of Washington; Pacific Pediatric... and other collaboratorsRecruitingMedulloblastoma | Medulloblastoma, Childhood | Medulloblastoma RecurrentUnited States